Jack Tsai

Background

About Jack Tsai

Biopharma business development and strategy executive with deep experience partnering with CEOs and boards to build, position, and scale oncology, cell therapy, CNS, and immunology based modalities.Over the past several years, I have operated in executive advisory and BD leadership roles, supporting early and clinical-stage companies on portfolio strategy, partnering, and external positioning globally. I am publicly identified as Head of BD or strategic advisor for select companies, reflecting formal leadership responsibilities rather than project-based consulting.I previously served as SVP at NKGen Biotech, where I led global business development and portfolio strategy across cell therapy programs in oncology and CNS. Earlier roles include senior BD and strategy leadership positions at Inhibrx, Takeda, and Sanofi (including Genzyme), with responsibility for partnerships, pipeline prioritization, and platform strategy.I continue to work closely with select companies in advisory and BD leadership roles while remaining open to senior executive opportunities where my experience can drive long-term value creation.